Search
for

    Sort by

    Research 181–210 of 1000+

    1. Five-alpha-reductase Inhibitors for prostate cancer prevention. The Cochrane library · 2008 · 37 citations
    2. Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document Journal of Cutaneous Medicine and Surgery · 2017 · 36 citations
    3. Hidradenitis Suppurativa in Children and Adolescents: A Review of Treatment Options Paediatric drugs · 2014 · 36 citations
    4. Testosterone Improves Antidepressant‐Emergent Loss of Libido in Women: Findings from a Randomized, Double‐Blind, Placebo‐Controlled Trial The Journal of Sexual Medicine · 2014 · 36 citations
    5. Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review Nutrients · 2021 · 36 citations
    6. Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia Frontiers in Pharmacology · 2020 · 35 citations
    7. Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review Sexual medicine reviews · 2013 · 35 citations
    8. Interventions for female pattern hair loss Cochrane Database of Systematic Reviews · 2012 · 35 citations
    9. When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome? Clinical Endocrinology · 2011 · 35 citations
    10. Azelaic Acid: Mechanisms of Action and Clinical Applications Clinical Cosmetic and Investigational Dermatology · 2024 · 34 citations
    11. Therapeutic potential of bimatoprost for the treatment of eyebrow hypotrichosis Drug Design Development and Therapy · 2018 · 34 citations
    12. Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review International Journal of Dermatology · 2018 · 34 citations
    13. Sex hormones and sarcopenia in older persons Current Opinion in Clinical Nutrition and Metabolic Care · 2012 · 34 citations
    14. Pharmacotherapy of polycystic ovary syndrome - an update Fundamental & Clinical Pharmacology · 2011 · 34 citations
    15. Fractional resurfacing in the Asian patient: Current state of the art Lasers in Surgery and Medicine · 2016 · 33 citations
    16. Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date Drug Design Development and Therapy · 2020 · 32 citations
    17. The Efficacy of Platelet-Rich Plasma in the Field of Hair Restoration and Facial Aesthetics—A Systematic Review and Meta-analysis Journal of Cutaneous Medicine and Surgery · 2019 · 31 citations
    18. In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss Journal of Ethnopharmacology · 2015 · 30 citations
    19. 5α-Reductase inhibitors in androgenetic alopecia Current Opinion in Endocrinology, Diabetes and Obesity · 2014 · 29 citations
    20. Parkinson's disease and skin 2021 · 28 citations
    21. Hidradenitis Suppurativa Mayo Clinic Proceedings · 2015 · 27 citations
    22. Innovative Uses for Zinc in Dermatology Dermatologic Clinics · 2010 · 27 citations
    23. New drugs under investigation for the treatment of alopecias Expert Opinion on Investigational Drugs · 2019 · 26 citations
    24. A randomized, double-blind, vehicle-controlled clinical study of hair regeneration using adipose-derived stem cell constituent extract in androgenetic alopecia Stem Cells Translational Medicine · 2020 · 25 citations
    25. Interventions for morphea Cochrane library · 2019 · 24 citations
    26. Relationships Between Biochemical Markers of Hyperandrogenism and Metabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis Hormone and Metabolic Research · 2019 · 22 citations
    27. Emerging Therapies for Acne Vulgaris American Journal of Clinical Dermatology · 2018 · 22 citations
    28. Dehydroepiandrosterone for women in the peri- or postmenopausal phase The Cochrane library · 2015 · 22 citations
    29. Pediatric Psychocutaneous Disorders American Journal of Clinical Dermatology · 2011 · 22 citations
    30. Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies Breast Cancer Research and Treatment · 2018 · 22 citations